List of countries by antidepressant consumption

This is a list of countries by antidepressant consumption according to data published by the OECD.

OECD list

The source for the data below is the OECD Health Statistics 2018, released by the OECD in June 2018 and updated on 8 November 2018.[1]

The unit of measurement used by the OECD is defined daily dose (DDD), defined as "the assumed average maintenance dose per day for a drug used on its main indication in adults".[2] The sources used by the OECD are primarily national health authorities.[2] Definitions, sources and methodology per country is explained further in a document available on the OECD website.[2] The OECD have not included the United States in these reviews, but if added the country would have the highest or second-highest rate.[3]

Country Defined daily dosage
per 1 000 inhabitants per day		 Year Data include drugs
dispensed in hospitals		 Data include non-
reimbursed drugs		 Data include OTC
drugs		 Notes
 Iceland141.42017YesYesYes
 Australia106.72016NoYesNo
 Portugal103.62017NoYes[note 1]Yes[note 2]
 United Kingdom100.12016NoNoN/A
 Canada99.62017NoNoSee note[note 3][note 4]
 Sweden96.82017YesYesYes[note 5]
 Belgium792016NoNoNo
 Denmark772015YesYesYes
 Spain75.52016NoNoNo
 New Zealand72.82014N/AN/AN/A[note 6]
 Finland67.62016Yes[note 7]YesYes
 Austria60.52016No[note 8]See note[note 9]No
 Slovenia58.62016NoSee note[note 10]See note[note 11]
 Norway57.12017YesYesYes
 Czech Republic57.12016YesYesYes
 Germany56.52016NoSee note[note 12]No
 Luxembourg52.72017NoNoNo[note 4]
 France49.82009Yes[note 13]YesYes
 Israel49.22017NoNoNo
 Greece48.12015NoNoNo[note 6]
 Netherlands46.12016NoNoNo
 Chile41.42017YesN/AYes
 Turkey412016NoYesSee note[note 14]
 Italy40.32017N/ANoNo[note 15]
 Slovakia38.92016YesYesYes
 Hungary28.82017NoNoNo
 Estonia28.82017YesYesYes
 South Korea19.92016YesYesYes
 Latvia13.32016N/AN/AN/A

See also

Notes
  1. Data include both reimbursed and non-reimbursed products.
  2. Yes, but only OTC products sold in pharmacies.
  3. Generally, claims for OTC drugs are not reimbursed, but OTC drugs are not explicitly excluded.
  4. Provisional value.
  5. Data include OTC drugs both from pharmacies and from other retailers.
  6. Difference in methodology.
  7. Data are based on wholesale of pharmaceuticals.
  8. Drug consumption in hospitals and in hospital ambulances is excluded.
  9. Data cover only drugs reimbursed by the sickness funds within the statutory health insurance.
  10. Data include all medicines with a medical prescription – compulsory health insurance, regardless of the reimbursement.
  11. Only OTC drugs with a medical prescription.
  12. Data contain exclusively the drug consumption debited to the statutory health insurance (i.e. drugs reimbursed by German Statutory Health Insurance).
  13. Data include drug consumption both in hospitals and in pharmacies.
  14. Data include drugs dispensed in pharmacies and non-reimbursed drugs.
  15. Estimated value.

References
  1. "OECD Health Statistics 2018". OECD. 28 June 2018. Retrieved 10 May 2019.
  2. "OECD Health Statistics 2018: Definitions, Sources and Methods". OECD. June 2018. Retrieved 10 May 2019.
  3. Gould, S.; L.F. Friedman (4 February 2016). "Something startling is going on with antidepressant use around the world". Business Insider. Retrieved 18 July 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.